Literature DB >> 26662805

Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche.

Shirin Azizidoost1, Ahmad Ahmadzadeh1, Fakher Rahim1, Mohammad Shahjahani1, Mohammad Seghatoleslami1, Najmaldin Saki2.   

Abstract

Liver is the organ responsible for hematopoiesis during fetal life, which is also a target organ of metastasis for several cancers. In order to recognize the hepatic metastatic changes, obtain a better grasp of cancer prevention, treatment, and inhibition mode of hepatic metastasis progression, we investigate the changes and transformation of normal hepatic niche cells to metastatic niche ones in this review. On the other hand, since metastatic diseases alter the liver function, the changes in a number of cancers that metastasize to the liver have also been reviewed. Relevant English-language literature was searched and retrieved from PubMed (1994-2014) using the following keywords: hepatic stem cell niche, hepatic metastatic niche, chemokine, and microRNAs (miRNAs). Also, over 86 published studies were investigated, and bioinformatics analysis of differentially expressed miRNAs in hepatic cancer and metastasis was performed. Metastasis is developed in several stages with specific changes and mechanisms in each stage. Recognition of these changes would lead to detection of new biomarkers and clinical targets involved in specific stages of liver metastasis. Investigation of the hepatic stem cell niche, development of metastasis in liver tissue, as well as changes in chemokines and miRNAs in metastatic hepatic niche can significantly contribute to faster detection of liver metastasis progression.

Entities:  

Keywords:  Chemokine; Hepatic metastatic niche; Hepatic stem cell; MiRNA

Mesh:

Year:  2015        PMID: 26662805     DOI: 10.1007/s13277-015-4557-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  76 in total

1.  Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.

Authors:  Christoph Kahlert; Fee Klupp; Karsten Brand; Felix Lasitschka; Sven Diederichs; Johanna Kirchberg; Nuh Rahbari; Shamik Dutta; Ulrich Bork; Johannes Fritzmann; Christoph Reissfelder; Moritz Koch; Juergen Weitz
Journal:  Cancer Sci       Date:  2011-08-04       Impact factor: 6.716

2.  Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.

Authors:  Florian Schelter; Birgit Halbgewachs; Petra Bäumler; Caroline Neu; Agnes Görlach; Florian Schrötzlmair; Achim Krüger
Journal:  Clin Exp Metastasis       Date:  2010-10-30       Impact factor: 5.150

3.  Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis.

Authors:  Abdel-Majid Khatib; Patrick Auguste; Lucia Fallavollita; Ni Wang; Amir Samani; Maria Kontogiannea; Sarkis Meterissian; Pnina Brodt
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

4.  Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Authors:  Terence K Lee; Ronnie T P Poon; Anthony P Yuen; Ming Tat Ling; Wei Kei Kwok; Xiang Hong Wang; Yong Chuan Wong; Xin Yuan Guan; Kwan Man; King Lok Chau; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

5.  Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

Authors:  A P Levy; N S Levy; S Wegner; M A Goldberg
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

6.  Metastatic tumor cell arrest in the liver-lumen occlusion and specific adhesion are not exclusive.

Authors:  Peter Gassmann; Andre Hemping-Bovenkerk; Soeren Torge Mees; Joerg Haier
Journal:  Int J Colorectal Dis       Date:  2009-03-25       Impact factor: 2.571

Review 7.  A microphysiological system model of therapy for liver micrometastases.

Authors:  Amanda M Clark; Sarah E Wheeler; Donald P Taylor; Venkateswaran C Pillai; Carissa L Young; Rachelle Prantil-Baun; Transon Nguyen; Donna B Stolz; Jeffrey T Borenstein; Douglas A Lauffenburger; Raman Venkataramanan; Linda G Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2014-05-12

8.  Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice.

Authors:  Akihide Kamiya; Sei Kakinuma; Yuji Yamazaki; Hiromitsu Nakauchi
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

9.  Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Authors:  Charlotte Kopitz; Michael Gerg; Obul Reddy Bandapalli; Dilek Ister; Caroline J Pennington; Stephanie Hauser; Christin Flechsig; Hans-Willi Krell; Dalibor Antolovic; Keith Brew; Hideaki Nagase; Manfred Stangl; Claus W Hann von Weyhern; Björn L D M Brücher; Karsten Brand; Lisa M Coussens; Dylan R Edwards; Achim Krüger
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 10.  Adult Hepatic Progenitor Cell Niche: How it affects the Progenitor Cell Fate.

Authors:  Aezam Katoonizadeh; Hossein Poustchi
Journal:  Middle East J Dig Dis       Date:  2014-04
View more
  4 in total

Review 1.  Extracellular Matrix Alterations in Metastatic Processes.

Authors:  Mayra Paolillo; Sergio Schinelli
Journal:  Int J Mol Sci       Date:  2019-10-07       Impact factor: 5.923

2.  Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study.

Authors:  Yingnan Yang; Zhuolong Tu; Chentao Ye; Huajie Cai; Shouzhang Yang; Xuehai Chen; Jinfu Tu
Journal:  BMC Surg       Date:  2021-01-23       Impact factor: 2.102

Review 3.  Therapeutic Targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer.

Authors:  Rhynelle S Dmello; Sarah Q To; Ashwini L Chand
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

4.  Engineering the pre-metastatic niche.

Authors:  Brian A Aguado; Grace G Bushnell; Shreyas S Rao; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Nat Biomed Eng       Date:  2017-06-13       Impact factor: 25.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.